These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1607031)

  • 1. Advanced breast cancer in Egyptian women: clinical features and response to endocrine therapy. The Anglo-Egyptian Health Agreement Collaborative Study.
    Richards MA; Coleman RE; Hamsa R; Khaled H; el Mawla MG; Kadry I; Hablas A; Ramadan M; Allen D; Wang DY
    Eur J Surg Oncol; 1992 Jun; 18(3):219-23. PubMed ID: 1607031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hormone levels in breast cancer patients and controls in Egypt and Great Britain. The Anglo-Egyptian Health Agreement Collaborative Study.
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1329-35. PubMed ID: 3181253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.
    Buchanan RB; Blamey RW; Durrant KR; Howell A; Paterson AG; Preece PE; Smith DC; Williams CJ; Wilson RG
    J Clin Oncol; 1986 Sep; 4(9):1326-30. PubMed ID: 3528402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.
    Rubens RD; Tinson CL; Coleman RE; Knight RK; Tong D; Winter PJ; North WR
    Br J Cancer; 1988 Nov; 58(5):626-30. PubMed ID: 3219274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer.
    Wang DY; Rubens RD; Clark GM; Moore JW; Bulbrook RD
    Breast Cancer Res Treat; 1988 Apr; 11(1):67-70. PubMed ID: 3382764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.
    Ingle JN; Krook JE; Green SJ; Kubista TP; Everson LK; Ahmann DL; Chang MN; Bisel HF; Windschitl HE; Twito DI
    J Clin Oncol; 1986 Feb; 4(2):178-85. PubMed ID: 3511184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
    Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
    Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose medroxyprogesterone acetate versus oophorectomy as first-line therapy of advanced breast cancer in premenopausal patients.
    Martoni A; Longhi A; Canova N; Pannuti F
    Oncology; 1991; 48(1):1-6. PubMed ID: 1824798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer.
    Stewart JF; Rubens RD; King RJ; Minton MJ; Steiner R; Tong D; Winter PJ; Knight RK; Hayward JL
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1307-14. PubMed ID: 6891929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?
    Thewes B; Meiser B; Duric VM; Stockler MR; Taylor A; Stuart-Harris R; Links M; Wilcken N; McLachlan SA; Phillips KA; Beith J; Boyle F; Friedlander ML
    Lancet Oncol; 2005 Aug; 6(8):581-8. PubMed ID: 16054569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre.
    Cheung KL; Owers R; Robertson JF
    Endocr Relat Cancer; 2006 Mar; 13(1):251-5. PubMed ID: 16601292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen and oophorectomy in the treatment of recurrent breast cancer: a Southwest Oncology Group Study.
    Hoogstraten B; Fletcher WS; Gad-el-Mawla N; Maloney T; Altman SJ; Vaughn CB; Foulkes MA
    Cancer Res; 1982 Nov; 42(11):4788-91. PubMed ID: 7127314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal approaches to breast cancer treatment and prevention: an overview.
    Vogel CL
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):2-9. PubMed ID: 8824459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen therapy in postmenopausal advanced breast cancer: efficacy at the primary tumor site in 46 evaluable patients.
    Veronesi A; Frustaci S; Tirelli U; Galligioni E; Trovò MG; Crivellari D; Magri MD; Tumolo S; Grigoletto E
    Tumori; 1981; 67(3):235-8. PubMed ID: 7281242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial to investigate the usefulness of the addition of prednisolone to tamoxifen as adjuvants to mastectomy in primary breast cancer patients with a high risk of recurrence: a preliminary report.
    DiMartino L; Demontis B; Mitchell IP; Hayward SW; Deshpande N
    Anticancer Res; 1991; 11(2):869-72. PubMed ID: 2064345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
    Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD
    Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial.
    Thürlimann B; Hess D; Köberle D; Senn I; Ballabeni P; Pagani O; Perey L; Aebi S; Rochlitz C; Goldhirsch A
    Breast Cancer Res Treat; 2004 Jun; 85(3):247-54. PubMed ID: 15111763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.